The Research and Development team at Vyriad is focused on innovating and advancing engineered virus therapies for cancer treatment. This team collaborates on designing and optimizing viral therapies, conducting preclinical studies, and ensuring scientific rigor in the development process to create effective solutions that target cancer cells while engaging the immune system. Their multidisciplinary expertise spans intellectual property, clinical strategies, and comparative oncology, driving the progression from laboratory research to potential therapeutic applications.
View all